transcorneal electrical stimulation therapy for optic neuropathies and retinal degenerative diseases

transcorneal electrical stimulation therapy for optic neuropathies and retinal degenerative diseases - TES for optic neuropathies and retinal degenerative diseases

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005049

Enrollment

540

Registered

2011-02-08

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

optic neuropathies and retinal degenerative diseases

Interventions

1mA-20Hz-30min 0.3mA-20Hz-30min

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: TON, NAION, Glaucoma, IOA, retinitis pigmentosa Visual acuity 0.1 to 0.7 no systematic diseases accepted informed consent age 18 to 80 years old

Exclusion criteria

Exclusion criteria: other ocular diseases brain tumor, brain attack AION cochlear implants pregnancy

Design outcomes

Primary

Measure	Time frame
enhenched visual acuity, enhanced visual field and safety 1, 3, 6, 12 months after treatment	—

Countries

Japan

Contacts

Public ContactTakeshi Morimoto

osaka university graduate school of medicine department of applied visual science

06-6879-3941

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026